Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 199
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M
Q3’25 Psychedelic Lobbying Update
Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher
The Psychedelic News Feed: October 20 – 26, 2025
Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed
Psyched Wellness Presents AME-1 to Health Canada in Pre-Submission Meeting
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial...
Michael Falvey joins COMPASS Pathways as Chief Financial Officer
Silo Pharma Announces Grant of U.S. Patent For its Novel CNS...
The Wild World of 19th Century Psychedelics
PTSF87 – Ketamine, Addiction, and Mysticism + Kelsey Ramsden of MINDCURE
Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry
Ibogaine and Cardiac Arrhythmia: The Heart of the Matter
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening...
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals...
1
...
198
199
200
...
300
Page 199 of 300
